Short report
Range of cross reactivity of anti-GM1 IgG antibody in
Guillain-Barré syndrome
M Koga, M Tatsumoto, N Yuki, K Hirata
From the
Department of Neurology, Dokkyo University School of Medicine,
Kitakobayashi 880, Mibu, Shimotsuga, Tochigi 321-0293,
Japan
Correspondence to: Dr N Yuki yuki{at}dokkyomed.ac.jp
Received 19 October
2000 and in revised form 1 March 2001;
Accepted 6 March
2001
The cross reactivity of anti-GM1 IgG antibody with
various gangliosides and asialo-GM1 in serum samples from 27 patients
with Guillain-Barré syndrome was investigated. An enzyme linked
immunosorbent assay (ELISA) absorption study showed that anti-GM1 IgG
antibody cross reacted with asialo-GM1 in 52% of the patients, GM1b in 41%, GD1b in 22%, and GalNAc-GD1a in 19%, and that it did not cross
react with GM2, GT1b, or GQ1b. The antibody that cross reacted with
GD1b was associated with a high frequency of cranial nerve involvement
and negative Campylobacter jejuni serology.
Anti-GM1 IgG antibody has a broad range of cross reactivity which may
contribute to various clinical variations of Guillain-Barré syndrome.
Keywords: Guillain-Barré syndrome; anti-GM1 antibody; cross reactivity
© 2001 by Journal of Neurology, Neurosurgery, and Psychiatry
This article has been cited by other articles:
-
Koga, M, Yoshino, H, Morimatsu, M, Yuki, N
(2002). Anti-GT1a IgG in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry
72: 767-771
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
